Skip to main content
Premium Trial:

Request an Annual Quote

Ariadne to Distribute Aureus Informatics Products in US

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Ariadne today said that it will distribute Aureus Pharma's informatics products in the US, and the firms will collaborate on potential combinations of their technologies.

The firms will explore synergies between their respective knowledge management systems, said Rockville, Md.-based Ariadne, with a specific focus on the interfaces between the protein pathway space and medicinal chemistry. They believe such interfaces could help researchers better understand mechanisms of action between therapeutic proteins, protein pathways, and small molecules, as well as provide new insights in the disease biology area.

"We can provide solutions that enable customers to take advantage of both Ariadne and Aureus' products where it makes sense in their organization, workflow, and informatics infrastructure," Ariadne CEO Ilya Mazo said in a statement.

Financial terms of the alliance were not disclosed.

Paris-based Aureus sells the Aurscope database line, which focuses on GPCRs, kinases, ion channels, proteases, and nuclear receptors.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.